2
Views
34
CrossRef citations to date
0
Altmetric
Articles

The Disease Activity of Ulcerative Colitis and Crohn’s Disease

&
Pages 403-408 | Received 30 Sep 1975, Accepted 11 Nov 1975, Published online: 09 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

S.-W. Han, E. McColl, N. Steen, J. R. Barton, M. R. Welfare. (1998) The Inflammatory Bowel Disease Questionnaire: A Valid and Reliable Measure in Ulcerative Colitis Patients in the North East of England. Scandinavian Journal of Gastroenterology 33:9, pages 961-966.
Read now
J. Kjeldsen & O. B. Schaffalitzky De Muckadell. (1993) Assessment of Disease Severity and Activity in Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 28:1, pages 1-9.
Read now
J. Ejderhamn, G. Hedenborg & B. Strandvik. (1992) Long-term double-blind study on the influence of dietary fibres on faecal bile acid excretion in juvenile ulcerative colitis. Scandinavian Journal of Clinical and Laboratory Investigation 52:7, pages 697-706.
Read now
A. Hermanowicz, Z. Śliwiński, A. Nowak & L. Gajos. (1987) The Effect of Levamisole on the Maintenance of Remission of Ulcerative Colitis:A 2-Year Double-Blind Study. Scandinavian Journal of Gastroenterology 22:3, pages 367-371.
Read now
S. H. Saverymuttu, A. M. Peters, H. J. F. Hodgson & V. S. Chadwick. (1983) Assessment of Disease Activity in Ulcerative Colitis Using Indium-111-Labelled Leukocyte Faecal Excretion. Scandinavian Journal of Gastroenterology 18:7, pages 907-912.
Read now
Ingebrigt Talstad & Hans Fredrik Haugen. (1979) The relationship between the erythrocyte sedimentation rate (ESR) and plasma proteins in clinical materials and models. Scandinavian Journal of Clinical and Laboratory Investigation 39:6, pages 519-524.
Read now

Articles from other publishers (28)

Honghui Zhou & Diane R. MouldReena Khanna & Brian G. Feagan. 2019. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases 25 42 .
Grazyna Piotrowicz, Agnieszka Klufczyńska, Jacek Kowerzanow, Piotr Banaszkiewicz,Grażyna Rydzewska. (2018) Crohn’s disease activity evaluation based on imaging studies and biomarkers. Gastroenterology & Hepatology: Open Access 9:2.
Crossref
Shihoko Komine-Aizawa, Hideki Masuda, Takerou Mazaki, Motomi Shiono, Satoshi Hayakawa & Tadatoshi Takayama. (2015) Plasma Osteopontin Predicts Inflammatory Bowel Disease Activities. International Surgery 100:1, pages 38-43.
Crossref
Olga Y. KorolkovaJeremy N. MyersSamuel T. PellomLi Wang & Amosy E. M'koma. (2015) Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clinical Medicine Insights: Gastroenterology 8, pages CGast.S20612.
Crossref
Shannon Chang. (2015) Disease monitoring in inflammatory bowel disease. World Journal of Gastroenterology 21:40, pages 11246.
Crossref
David B. Sachar. (2014) Role of Biomarkers in the Study and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:12, pages 2511-2518.
Crossref
Reena Khanna, Guillaume Bouguen, Brian G. Feagan, Geert DʼHaens, William J. Sandborn, Elena Dubcenco, K. Adam Baker & Barrett G. Levesque. (2014) A Systematic Review of Measurement of Endoscopic Disease Activity and Mucosal Healing in Crohnʼs Disease. Inflammatory Bowel Diseases 20:10, pages 1850-1861.
Crossref
Bruce E. Sands & Corey A. Siegel. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 1941 1973.e9 .
A H L MULDER, J BROEKROELOFS, G HORST, P C LIMBURG, G F NELIS & C G M KALLENBERG. (1994) Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clinical and Experimental Immunology 95:3, pages 490-497.
Crossref
Hiroyuki Mitomi, Yasuo Ohkura, Kaoru Yokoyama, Miwa Sada, Kiyonori Kobayashi, Satoshi Tanabe, Naoshi Fukui, Hideki Kanazawa, Ichiro Kishimoto & Katsunori Saigenji. (2007) Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease. Pathology - Research and Practice 203:10, pages 717-723.
Crossref
Alexander D. Rodgers & Adrian G. Cummins. (2007) CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease. Digestive Diseases and Sciences 52:9, pages 2063-2068.
Crossref
Franck Carbonnel, Anne Lavergne, Marc Lémann, Alain Bitoun, Patrice Valleur, Pierre Hautefeuille, Annie Galian, Robert Modigliani & Jean-Claude Rambaud. (1994) Colonoscopy of acute colitis. Digestive Diseases and Sciences 39:7, pages 1550-1557.
Crossref
J. Broekroelofs, A. H. L. Mulder, G. F. Nelis, B. D. Westerveld, J. W. Cohen Tervaert & C. G. M. Kallenberg. (1994) Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Digestive Diseases and Sciences 39:3, pages 545-549.
Crossref
R Porschen, U Robin, A Schumacher, S Schauseil, F Borchard, K J Hengels & G Strohmeyer. (1992) DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study.. Gut 33:5, pages 663-667.
Crossref
John W. Garrett & Douglas A. Drossman. (1990) Health status in inflammatory bowel disease. Gastroenterology 99:1, pages 90-96.
Crossref
MICHAEL CAMILLERI & MARITZA PROANO. (1989) Advances in the Assessment of Disease Activity in Inflammatory Bowel Disease. Mayo Clinic Proceedings 64:7, pages 800-807.
Crossref
F. D. L. BARTHOLOMEUSZ & D. J. C. SHEARMAN. (2008) Measurement of activity in Crohn's disease. Journal of Gastroenterology and Hepatology 4:1, pages 81-94.
Crossref
Robert S. Sandler, Matthew C. Jordan & Lawrence L. Kupper. (1988) Development of a Crohn's index for survey research. Journal of Clinical Epidemiology 41:5, pages 451-458.
Crossref
B. S. Rameh, F. M. Stevens & C. F. McCarthy. (1988) Hyposplenism in inflammatory Bowel disease. Irish Journal of Medical Science 157:1, pages 8-9.
Crossref
I. T. Beck. (1987) Laboratory assessment of inflammatory bowel disease. Digestive Diseases and Sciences 32:S12, pages S26-S41.
Crossref
C. Prantera, S. Levenstein, R. Capocaccia, S. Mariotti, C. Luzi, R. Cosintino & M. Simi. (1987) Prediction of surgery for obstruction in Crohn's ileitis. Digestive Diseases and Sciences 32:12, pages 1363-1369.
Crossref
S. Fasth, L. Hultén, O. Magnusson, S. Nordgren & I. Warnold. (1987) The immediate and long-term effects of postoperative total parenteral nutrition on body composition. International Journal of Colorectal Disease 2:3, pages 139-145.
Crossref
S. Fasth, L. Hultén, O. Magnusson, S. Nordgren & I. Warnold. (1987) Postoperative complications in colorectal surgery in relation to preoperative clinical and nutritional state and postoperative nutritional treatment. International Journal of Colorectal Disease 2:2, pages 87-92.
Crossref
A. Pera, P. Bellando, D. Caldera, V. Ponti, M. Astegiano, C. Barletti, E. David, A. Arrigoni, G. Rocca & G. Verme. (1987) Colonoscopy in inflammatory bowel disease. Gastroenterology 92:1, pages 181-185.
Crossref
Cosimo Prantera, Carlo Luzi, Piero Olivotto, Susan Levenstein, Paola Cerro & Angelo Fanucci. (1984) Relationship between clinical and laboratory parameters and length of lesion in Crohn's disease of small bowel. Digestive Diseases and Sciences 29:12, pages 1093-1097.
Crossref
A Hermanowicz, A Nowak & L Gajos. (1984) Controlled therapeutic trial of levamisole and sulphasalazine in acute ulcerative colitis.. Gut 25:5, pages 534-538.
Crossref
N S Ambrose, M R Keighley, J Alexander-Williams & R N Allan. (1984) Clinical impact of colectomy and ileorectal anastomosis in the management of Crohn's disease.. Gut 25:3, pages 223-227.
Crossref
S. Kaufman, B. Chalmer, R. Heilman & W. Beeken. (1979) A prospective study of the course of Crohn's disease. Digestive Diseases and Sciences 24:4, pages 269-276.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.